Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Graystone who wrote (4916)	7/16/1998 9:59:00 AM
From: mc	Read Replies (2) \| Respond to of 7041

I think I have a better one for this thread, Graystone, "Ain't we got all the fools in town on our side? And ain't that enough of a majority in any town?" As for ZONA, I can't figure this damn thing out. Does anyone know if they're going to make available any data regarding sales or efficacy from Mexico? It will be really interesting to see what happens as the moment of truth approaches. It seems the longs in this stock have the same strong will as the Vivus shorts. I'm curious as to whether the ZONA information vacuum will continue right up until NDA rejection/acceptance or if they'll actually provide some useful data so that we can judge the effectiveness of ZONA in the actual end-patient arena. Clinical studies are ok, but, they are just that - clinical. Look at the significantly lower effectiveness of MUSE in the lab vs. in the home - sometimes the differences are astounding (although the circumstances there are incorrect usage, I haven't actually heard of someone taking a pill incorrectly ;) ) Good luck, Gary